Cargando…

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock

Cardiogenic shock (CS) remains a leading cause of hospital death. However, the use of mechanical circulatory support has fundamentally changed CS management over the last decade and is rapidly increasing. In contrast to extracorporeal membrane oxygenation as well as counterpulsation with an intraaor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attinger-Toller, Adrian, Bossard, Matthias, Cioffi, Giacomo Maria, Tersalvi, Gregorio, Madanchi, Mehdi, Bloch, Andreas, Kobza, Richard, Cuculi, Florim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984099/ https://www.ncbi.nlm.nih.gov/pubmed/35402561 http://dx.doi.org/10.3389/fcvm.2022.856870

Ejemplares similares

Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry
por: Bossard, Matthias, et al.
Publicado: (2022)

Trajectories of Cardiac Function Following Treatment With an Impella Device in Patients With Acute Anterior ST-Elevation Myocardial Infarction
por: Tersalvi, Gregorio, et al.
Publicado: (2022)

Pushing the Boundaries: Drug-Coated Balloons to Treat a Calcified and Thrombotic Lesion in Acute Coronary Syndrome
por: Cioffi, Giacomo Maria, et al.
Publicado: (2022)

Manual compression versus MANTA device for access management after impella removal on the ICU
por: Cuculi, Florim, et al.
Publicado: (2022)

The Importance of Defining the Coronary Anatomy in Suspected Myopericarditis: A Case Report
por: Madanchi, Mehdi, et al.
Publicado: (2021)

Metal free percutaneous coronary interventions in all-comers: First experience with a novel sirolimus-coated balloon
por: Madanchi, Mehdi, et al.
Publicado: (2022)

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Madanchi, Mehdi, et al.
Publicado: (2021)

Deferring stent optimization in stent thrombosis: A novel approach for STEMI management—Insights from a case series
por: Cioffi, Giacomo Maria, et al.
Publicado: (2021)

Mitigating the risk of flow deterioration by deferring stent optimization in STEMI patients with large thrombus burden: Insights from a prospective cohort study
por: Cioffi, Giacomo Maria, et al.
Publicado: (2023)

Cardiac resynchronization therapy in patients with a coronary sinus reducer: a case series
por: Grebmer, Christian, et al.
Publicado: (2023)

“Burying” covered coronary stents under drug-eluting stents: A novel approach to ensure long-term stent patency
por: Bossard, Matthias, et al.
Publicado: (2023)

Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
por: Kofler, Thomas, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience
por: Matassini, M. V., et al.
Publicado: (2023)

Chest pain and plaque rupture without high-sensitive troponin elevation
por: Moccetti, Federico, et al.
Publicado: (2019)

Predictors of paravalvular leak following implantation of the ACURATE neo transcatheter heart valve: the PREDICT PVL study
por: Brinkert, Miriam, et al.
Publicado: (2020)

Rationale and Design of JenaMACS—Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock
por: Haertel, Franz, et al.
Publicado: (2022)

The “TIDE”-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach
por: Tschöpe, Carsten, et al.
Publicado: (2021)

Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle
por: Josiassen, Jakob, et al.
Publicado: (2020)

Insertion of Impella(®) in a Patient With an Evolut(TM)PRO Prosthesis
por: Tamura, Yudai, et al.
Publicado: (2020)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

miRNA-200b—A Potential Biomarker Identified in a Porcine Model of Cardiogenic Shock and Mechanical Unloading
por: Riehle, Christian, et al.
Publicado: (2022)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Efficacy of Ranolazine for Treatment of Coronary Microvascular Dysfunction—A Systematic Review and Meta-analysis of Randomized Trials
por: Kofler, Thomas, et al.
Publicado: (2020)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Biventricular Unloading with Impella and Venoarterial Extracorporeal Membrane Oxygenation in Severe Refractory Cardiogenic Shock: Implications from the Combined Use of the Devices and Prognostic Risk Factors of Survival
por: Chatzis, Georgios, et al.
Publicado: (2021)

Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device
por: Feghaly, Julien, et al.
Publicado: (2021)

Impella Use in Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction
por: Mohammedzein, Assad, et al.
Publicado: (2019)

Unloading in Refractory Cardiogenic Shock After Out-Of-Hospital Cardiac Arrest Due to Acute Myocardial Infarction—A Propensity Score-Matched Analysis
por: Sieweke, Jan-Thorben, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_upr2r0dhvjfub5ke1olg8m7dv9